Abstract
Purpose
In a nonrandomized, prospective study the efficacy of radiotherapy with 16 and 20 Gray (Gy) for subfoveal neovascularization in age-related macular degeneration (ARMD) was analysed.
Material and Methods
From 1996 to 1998, 63 eyes were irradiated with 16 Gy and 38 eyes with 20 Gy for exudative ARMD. A total of 12 eyes had classic ARMD, 89 eyes occult ARMD, median baseline visual acuity (VA) was 6/30 (range: 3/60–6/9.5), median age was 78 years. Risk factors (type of ARMD, baseline VA) were evenly distributed in both groups. Median follow-up was 1.3 years (range: 4 months–4.7 years). VA of ±1 line or better and unchanged size and activity of the membrane in fluorescein angiography were defined as stable. Actuarial methods were used.
Results
Median loss of VA was −3 lines (range: −14 to +5), neovascularization remained unchanged or decreased in size and activity in 35 eyes. At 18 months, the probability of stabilized VA was 0.4 (95% confidence interval (CI): 0.3–0.5), at 24 months 0.3 (95% CI: 0.2–0.4). Radiation dose, type of ARMD or baseline VA had no significant impact on outcome of VA and membrane size and activity (P>0.05). Side effects were mild and transient increased tearing.
Conclusion
In this study, the results after radiotherapy were comparable to the natural course of the disease. An impact of radiation dose (16 vs20 Gy) on stabilizing visual acuity and subfoveal neovascularization could not be shown. The results of studies on dose escalation using very small fields and high radiation doses should be awaited.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA et al. The Framingham Eye Study monograph. Surv Ophthalmol 1980; 24(Suppl): 335–410.
Bergink GJ, Hoyng CB, van der Maazen RW, Vingerling JR, van Daal WA, Deutman AF . Visual acuity and scar size in eyes with age-related subfoveal choroidal neovascular lesions, 30 months after radiation therapy. Doc Ophthalmol 1996; 92: 61–75.
Chakravarthy U, Houston RF, Archer DB . Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol 1993; 77: 265–273.
Hart PM, Chakravarthy U, MacKenzie G, Archer DB, Houston RF . Teletherapy for subfoveal choroidal neovascularisation of age-related macular degeneratio: results of follow up in a non-randomised study. Br J Ophthalmol 1996; 80: 1046–1050.
Mauget-Faysse M, Chiquet C, Milea D, Romestaing P, Gèrard JP, Martin P et al. Long term results of radiotherapy for subfoveal choroidal neovascularistion in age related macular degeneration. Br J Ophthalmol 1999; 83: 923–928.
Gripp S, Stammen J, Petersen C, Hartmann A, Willers R, Althaus C . Radiotherapy in age-related macula degeneration. Int J Radiat Oncol Biol Phys 2002; 52: 489–495.
Bergink GJ, Hoyng CB, van der Maazen RWM, Vingerling JR, van Daal WA, Deutman AF . A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation. Graefe's Arch Clin Exp Ophthlamol 1998; 236: 321–325.
Fine SL, Maguire MG . It is not time to abandon radiotherapy for neovascular age-related macular degeneration. Arch Ophthalmol 2001; 119: 275–276.
Bressler NM, Frost LA, Bressler SB, Murphy RP, Fine SL . Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch Ophthalmol 1988; 106: 1537–1542.
Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal lesions in age-related macular degeneration: updated findings from two clinical trials. Arch Ophthalmol 1993; 111: 1200–1209.
Frank RN, Amin RH, Elliott D, Puklin JE, Abrams GW . Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 1996; 122: 393–403.
Holz FG, Pauleikhoff D (eds). Altersabhängige Makuladegeneration. Springer : Berlin, 1997.
Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PT . Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 1997; 81: 154–162.
Pauleikhoff D, Harper CA, Marshall J, Bird AC . Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology 1990; 97: 171–178.
Killingsworth HC, Sarks JP, Sarks SH . Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 1990; 4: 613–621.
Lopez PF, Grossniklaus HE, Lambert MH, Aaberg TM, Capone A, Sternberg P et al. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 1991; 112: 647–656.
Chakravarthy U, Biggart JH, Gardiner TA, Archer DB, Maguire CJ . Focal irradiation of perforating eye injuries: minimum effective dose and optimum time of irradiation. Curr Eye Res 1989; 8: 1241–1250.
Chakravarthy U, Gardiner TA, Archer DB, Maguire CJ . A light microscopic and autoradiographic study of non-irradiated and irradiated ocular wounds. Curr Eye Res 1989; 8: 337–348.
De Gowin RL, Lewis LJ, Hoak JC, Mueller AL, Gibson DP . Radiosensitivity of human endothelial cells in culture. J Lab Clin Med 1974; 81: 42–48.
Rosander K, Zackrisson B . DNA damage in human endothelial cells after irradiation in anoxia. Acta Oncol 1995; 34: 111–116.
Hosoi Y, Yamamoto Y, Ono T, Sakamoto K . Prostacyclin production in cultured endothelial cells is highly sensitive to low doses of ionizing radiation. Int J Radiat Oncol Biol Phys 1993; 63: 631–638.
Mooteri SN, Podolski JL, Drab EA, Saclarides TJ, Onoda JM, Kantak SS . WR 1065 and radioprotection of vascular endothelial cells. II Morphology. Radiat Res 1996; 145: 217–224.
Rubin DB, Drab EA, Kang HJ, Baumann FE, Blazek ER . WR 1065 and radioprotection of vascular endothelial cells. I Cell proliferation, DNA synthesis and damage. Radiat Res 1996; 145: 210–216.
Waters CM, Taylor JM, Molteni A, Ward WF . Dose response effects of radiation on the permeability of endothelial cells in culture. Radiat Res 1996; 146: 321–328.
Langley RE, Bump EA, Quartuccio SG, Medeiros D, Braunhut SJ . Radiation-induced apoptosis in microvascular endothelial cells. Br J Cancer 1997; 75: 666–672.
Archambeau JO, Mao XW, Yonemoto LT, Slater JD, Friedrichsen E, Teichman S et al. What is the role of radiation in the treatment of subfoveal membranes. Review of radiobiologic, pathologic, and other considerations to initiate a multimodality discussion. Int J Radiat Oncol Biol Phys 1998; 40: 1125–1136.
Miyamoto H, Kimura H, Yasukawa T, Honda Y, Tabata Y, Ikada Y et al. Effect of focal X-ray irradiation on experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 1999; 40: 1496–1502.
Spaide RF, Guyer DR, McCormick B, Yannuzzi LA, Burke K, Mendelsohn M et al. External beam radiation therapy for choroidal neovascularization. Ophthalmology 1998; 105: 24–30.
Postgens H, Bodanowitz S, Kroll P . Low dose radiation therapy for age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 1997; 235: 656–661.
Prettenhofer U, Haas A, Mayer R, Oechs A, Pakisch B, Stranzl H et al. Role of radiotherapy in age-related macular degeneration: a prospective study. Strahlenther Onkol 1998; 174: 613–617.
Staar S, Krott R, Mueller RP, Bartz-Schmidt KU, Heimann K . External beam radiotherapy for subretinal neovascularization in age-related macular degeneration: is this treatment efficient? Int J Radiat Oncol Biol Phys 1999; 45: 467–473.
RAD. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related degeneration (RAD Study). Radiation therapy for age-related macular degeneration. Ophthalmol 1999; 106: 2239–2247.
Marcus DM, Sheils WC, Johnson MH, McIntosh SB, Leibach DB, Maguire A et al. External beam irradiation of subfoveal choroidal neovascularization of complicating age-related macular degeneration. Arch Ophthalmol 2001; 119: 171–180.
Schittkowski M, Schneider H, Grüschow K, Ziegler PG, Guthoff R, Fietkau R . 3 Jahre Erfahrung mit der niedrig dosierten fraktionierten perkutanen Teletherapie bei subfoveolären Neovaskularisationen. Strahlenther Onkol 2001; 177: 345–353.
Bergink GJ, Deutman AF, van den Broek JF, van Daal WA, van der Maazen RW . Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 1994; 232: 591–598.
Stalmans P, Leys A, Van Limbergen E . External beam radiotherapy (20 Gy, 2 fractions) fails to control the growth of choroidal neovascularization in age-related macular degeneration: a review of 111 cases. Retina 1997; 17: 481–492.
Eter N, Schüller H, Spitznas M . Radiotherapy for age-related macular degeneration: is there a benefit for classic CNV? Int Ophthalmol 2002; 24: 13–19.
Valmaggia C, Ries G, Ballinari P . Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial. Am J Opthalmol 2002; 133: 521–529.
Yonemoto LT, Slater JD, Blacharski PB . Dose response in the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: results of a Phase I/II dose escalation study using proton radiotherapy. J Radiosurg 2000; 3: 47–54.
Thoelen A, Meister A, Bernasconi PP, Messmer EP . Radiotherapie von subretinalen Neovaskularisationsmembranen bei altersabhängiger Makuladegeneration (AMD). Ophthalmologe 1998; 95: 691–698.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hoeller, U., Fuisting, B., Schwartz, R. et al. Results of radiotherapy of subfoveal neovascularization with 16 and 20 Gy. Eye 19, 1151–1156 (2005). https://doi.org/10.1038/sj.eye.6701743
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6701743
